Working Today for a Cure Tomorrow
Company Overview
CavoGene LifeSciences is committed to individuals worldwide who are impacted by various neurodegenerative diseases. We are dedicated to the discovery, development and commercialization of novel gene therapies that attenuate memory loss and increase synaptic neuroplasticity, such as Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, and Traumatic Brain Injury.
About Us
CavoGene LifeSciences is committed to individuals worldwide who are impacted by various neurodegenerative diseases.
Pipeline
Neuron specific gene therapy that delivers Caveolin-1 to promote neuronal plasticity & synaptic communication to facilitate neuronal repair
Careers
Advance your career with our wide range of roles. We support your development through training and real-world experience in the life sciences industry.
Get in Touch with CavoGene
Want to learn more about CavoGene or have a question about our approach? Use the contact form and let’s start a conversation.